• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Cigna still expecting Express Scripts deal to happen by year-end

Share:

September 3, 2018

Cigna  says it will update investors on its planned takeover of Express Scripts at upcoming meetings.

It has received approvals from 14 states on the deal. Approval from 15 more states are conditions for the close of the transaction, still expected to wind up by the end of this year.

Date: September 4, 2018

Source: Seeking Alpha

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Tyto Care Launches TytoHome Nationwide at Best Buy StoresTyto Care Launches TytoHome Nationwide at Best Buy Stores
  • Livongo Taps MDLive, Doctor on Demand for Virtual Care IntegrationLivongo Taps MDLive, Doctor on Demand for Virtual Care Integration
  • OnlyBoth Inc. Launches Engines For Comparative Analytics And Reporting Of Population Health Measures In City NeighborhoodsOnlyBoth Inc. Launches Engines For Comparative Analytics And Reporting Of Population Health Measures In City Neighborhoods
  • Addressing Health Equity: Practical Solutions to Address Variations in CareAddressing Health Equity: Practical Solutions to Address Variations in Care
  • Personal Training App’s $4.5M Aound Headlined By A-Rod, 24 Hour Fitness Founder, Corazon CapitalPersonal Training App’s $4.5M Aound Headlined By A-Rod, 24 Hour Fitness Founder, Corazon Capital
  • Evaluating Musculoskeletal Digital Health AppsEvaluating Musculoskeletal Digital Health Apps
  • Forbion Portfolio Company, Enterprise Therapeutics’ First-in-Class TMEM16A Potentiator Program for Treatment of Cystic Fibrosis and Other Respiratory Diseases Acquired by RocheForbion Portfolio Company, Enterprise Therapeutics’ First-in-Class TMEM16A Potentiator Program for Treatment of Cystic Fibrosis and Other Respiratory Diseases Acquired by Roche
  • UT Southwestern Medical Center Researchers Discover Alzheimer’s Vaccine, Hope To Test In Humans SoonUT Southwestern Medical Center Researchers Discover Alzheimer’s Vaccine, Hope To Test In Humans Soon

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications